Detalles de la búsqueda
1.
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP.
Ann Hematol
; 2024 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38900302
2.
REFLECT: prospective multicenter non-interventional study evaluating the effectiveness and safety of Sandoz rituximab (SDZ-RTX; Rixathon®) in combination with CHOP for the treatment of patients with previously untreated CD20-positive diffuse large B-cell lymphoma.
Ther Adv Hematol
; 14: 20406207231183765, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37492394
3.
Pseudotyped recombinant adeno-associated viral vectors mediate efficient gene transfer into primary human CD34(+) peripheral blood progenitor cells.
Cytotherapy
; 12(1): 107-12, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-19929455
4.
A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study.
Cytotherapy
; 11(8): 992-1001, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19929463
5.
Imatinib-supplemented myeloablative total-body irradiation/cyclophosphamide conditioning prior to allogeneic stem cell transplantation as consolidation treatment in patients with blast crisis of chronic myeloid leukemia.
Eur J Haematol
; 92(6): 546-9, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24527710
6.
Combination treatment of imatinib-sensitive and -resistant BCR-ABL-positive CML cells with imatinib and farnesyltransferase inhibitors.
Anticancer Res
; 26(3A): 2169-77, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16827161
7.
Myeloablative conditioning in myelofibrosis using i.v. treosulfan and autologous peripheral blood progenitor cell transplantation with high doses of CD34+ cells results in hematologic responses - follow-up of three patients.
Haematologica
; 90(2): ECR08, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15713582
8.
Level of CD 20-expression and efficacy of rituximab treatment in patients with resistant or relapsing B-cell prolymphocytic leukemia and B-cell chronic lymphocytic leukemia.
Leuk Lymphoma
; 43(1): 149-51, 2002 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11908720
9.
In vitro testing of drug combinations employing nilotinib and alkylating agents with regard to pretransplant conditioning treatment of advanced-phase chronic myeloid leukemia.
Cancer Chemother Pharmacol
; 74(2): 427-32, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25038611
10.
Efficient gene transfer with pseudotyped recombinant adeno-associated viral vectors into human chronic myelogenous leukemia cells.
Leuk Lymphoma
; 52(3): 483-90, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21323526
11.
Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells.
Cancer Chemother Pharmacol
; 66(2): 255-64, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19862526
12.
Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis.
Cancer
; 109(8): 1543-9, 2007 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17340589
13.
Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks.
Mol Ther
; 6(2): 272-8, 2002 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12349826
14.
Clonal analysis of individual marrow-repopulating cells after experimental peripheral blood progenitor cell transplantation.
Stem Cells
; 22(4): 570-9, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15277702
15.
Cross-resistance of imatinib mesylate and 17-AAG in imatinib-resistant cells that overexpress BCR-ABL.
Br J Haematol
; 121(4): 672-3, 2003 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12752112
16.
Quantitative real-time polymerase chain reaction shows that treatment with interferon reduces the initially upregulated PRV-1 expression in polycythemia vera patients.
Haematologica
; 88(3): 349-51, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12651277
17.
Combination of imatinib and established antileukemic treatment modalities for otherwise refractory BCR-ABL positive lymphoblastic leukemia.
Haematologica
; 87(12): ECR38, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12495909
Resultados
1 -
17
de 17
1
Próxima >
>>